Oncology Archives

Oncology

FDA approves new treatment for metastatic melanoma

The U.S. Food and Drug Administration has approved Yervoy (ipilimumab) for the treatment of patients with metastatic melanoma. Read more at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm1193237.htm.

Persistent fatigue after breast cancer may speed aging

Researchers have found that persistent fatigue in breast cancer survivors may be caused by disruption in the autonomic system, and could make some patients…

Statins lower prostate cancer recurrence

Men with high-risk prostate cancer who take statin drugs while receiving radiation therapy are less likely to have their cancer return than patients who…

Evidence-based interventions for constipation in patients with cancer

Editor’s note: One of a series of articles on managing cancer-related symptoms from the Oncology Nursing Society. Constipation is a common but often unrecognized…

The genetics of colorectal cancer

A 52-year-old patient arrives at the busy family practice office where you work for his follow-up visit. He had not undergone colon cancer screening,…

FDA advises women with breast impants

The U.S. Food and Drug Administration says women with breast implants may have a “very small, but increased risk” of developing anaplastic large cell…

Radiation therapy 101

More than half of cancer patients get radiation therapy. This article gives a basic overview of this potentially life-saving treatment, discusses nursing interventions for…

FDA recommends removing Avastin’s breast cancer indication

The U.S. Food and Drug Administration (FDA) is recommending that the breast cancer indication for Avastin be removed from its label “because the drug…

Evidence-based interventions for depression in patients with cancer

Editor’s note: One of a series of articles on managing cancer-related symptoms from the Oncology Nursing Society. Dana Jennings, in his New York Times…

New warning added for gonadotropin-releasing hormone agonists

The U.S. Food and Drug Administration has asked manufacturers to add new labeling warnings for gonadotropin-releasing hormone (GnRH) agonists, mostly used to treat men…

The role of pharmacogenomics in cancer

Oncology nurses have long appreciated that the “one size fits all” strategy—basing chemotherapy dosages on body surface area—for treating cancer does not work because…

What every nurse needs to know about breast cancer

Breast cancer strikes 1 in 8 American women. This article discusses recent diagnostic and treatment advances (including some you may not know about) that…

FDA approves new treatment for metastatic melanoma

Persistent fatigue after breast cancer may speed aging

Researchers have found that persistent fatigue in breast cancer survivors may be caused by disruption in the autonomic system, and could make…

Statins lower prostate cancer recurrence

Men with high-risk prostate cancer who take statin drugs while receiving radiation therapy are less likely to have their cancer return than…

Evidence-based interventions for constipation in patients with cancer

Editor’s note: One of a series of articles on managing cancer-related symptoms from the Oncology Nursing Society. Constipation is a common but…

The genetics of colorectal cancer

A 52-year-old patient arrives at the busy family practice office where you work for his follow-up visit. He had not undergone colon…

FDA advises women with breast impants

The U.S. Food and Drug Administration says women with breast implants may have a “very small, but increased risk” of developing anaplastic…

Radiation therapy 101

More than half of cancer patients get radiation therapy. This article gives a basic overview of this potentially life-saving treatment, discusses nursing…

FDA recommends removing Avastin’s breast cancer indication

The U.S. Food and Drug Administration (FDA) is recommending that the breast cancer indication for Avastin be removed from its label “because…

Evidence-based interventions for depression in patients with cancer

Editor’s note: One of a series of articles on managing cancer-related symptoms from the Oncology Nursing Society. Dana Jennings, in his New…

New warning added for gonadotropin-releasing hormone agonists

The U.S. Food and Drug Administration has asked manufacturers to add new labeling warnings for gonadotropin-releasing hormone (GnRH) agonists, mostly used to…

The role of pharmacogenomics in cancer

Oncology nurses have long appreciated that the “one size fits all” strategy—basing chemotherapy dosages on body surface area—for treating cancer does not…